Windtree Therapeutics
-
Warrington’s Windtree Therapeutics Agrees to Buy Fintech Platform CommLoan
Warrington-based Windtree Therapeutics has agreed to acquire commercial technology finance business CommLoan in its latest attempt to diversify its revenue streams, writes John George for…
-
Warrington’s Windtree Therapeutics Calls Off Acquisition of Titan Environmental Services
Windtree Therapeutics, based in Warrington, has hit another setback in its efforts to expand beyond drug development, canceling its acquisition of Titan Environmental Services, writes…
-
Amid Continued Financial Struggles, Warrington’s Windtree Therapeutics Shifts Focus
Following failed forays into real estate and crypto, Warrington-based Windtree Therapeutics is reinventing itself as a waste management and environmental services firm, writes John George…
-
Warrington’s Windtree Therapeutics Faces Uncertain Future After NASDAQ Delisting
Warrington-based Windtree Therapeutics faces an uncertain future after being delisted from the NASDAQ stock exchange last week, writes John George for the Philadelphia Business Journal.…
-
Warrington’s Windtree Therapeutics Signs Cryptocurrency Deal Worth Up To $200M
After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, Warrington-based Windtree Therapeutics has entered a…
-
Warrington’s Windtree Therapeutics Acquires Waste Management Company
Warrington-based Windtree Therapeutics continues to diversify its revenue streams with the acquisition of Titan Environmental Solutions, a waste management business, writes John George for the…
-
Warrington-Based Windtree Therapeutics Buys Huston Apartment Complex
Warrington-based Windtree Therapeutics is purchasing a 436-unit apartment complex in Texas as part of its strategy to generate revenue while continuing with the development of…
-
Warrington’s Windtree Therapeutics Eyes Acquisitions to Stay Afloat
To remain viable, Warrington-based Windtree Therapeutics plans on boosting revenue by acquiring smaller companies with FDA-approved products, writes John George for the Philadelphia Business Journal.…
-
Windtree Therapeutics Secures $12.9 Million Financing to Boost Operations and Eliminate Debt
Warrington biotechnology firm Windtree Therapeutics has secured financial stability through a $12.9 million financing arrangement, providing $3.4 million in new funding and eliminating $9.5 million…
-
Warrington-based Windtree Therapeutics Explores Strategic Options to Boost Shareholder Value
Warrington-based Windtree Therapeutics is currently exploring strategic alternatives to enhance shareholder value, including the possibility of acquisitions or being acquired, writes John George for the…
-
Warrington’s Windtree Therapeutics Partners with China-Based Lee’s Pharma for Heart Disease Drug Expansion in Asia
Warrington-based biopharmaceutical firm Windtree Therapeutics is entering a multimillion-dollar licensing deal with a Chinese drug company for its three new cardiovascular disease drug candidates, writes…
-
Bucks County Businesses Clawed by Recent Bearish Stock Market Volatility
The stock market’s January high is as distant a memory as New Year resolutions and wind chill reports. Since the start of June, performance has…
-
Warrington’s Windtree Therapeutics Succeeds in Trial of COVID-Related Lung Distress Treatment
A Phase 2 test by Windtree Therapeutics of its drug treatment for Associated Acute Respiratory Distress Syndrome (ARDS) may hold hope for patients with damaged…
-
Warrington-based Windtree Therapeutics Finds Its New Executive Director of Clinical Development
Warrington-based Windtree Therapeutics, a biotechnology and medical device company, has appointed Joseph Soffer, M.D., F.A.C.C., as its new Executive Director of Clinical Development, effective immediately.…
Founding Partners
Advertisement
Affiliate Partners
